PHARMACOSMOS Trademark

Trademark Overview


On Monday, November 28, 2022, a trademark application was filed for PHARMACOSMOS with the United States Patent and Trademark Office. The USPTO has given the PHARMACOSMOS trademark a serial number of 79363592. The federal status of this trademark filing is REGISTERED as of Tuesday, July 2, 2024. This trademark is owned by Pharmacosmos Holding A/S. The PHARMACOSMOS trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload in humans; veterinary preparations for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload in animals; dietary supplements for human beings and animals; dietetic food and substances, namely, beverages adapted for medical and veterinary purposes; diagnostic preparations for medical and veterinary purposes; molecular weight testing reagents for diagnostic purposes; medical, pharmaceutical and veterinary preparations for parenteral administration, in particular oral, intravenous, intramuscular and subcutaneous, for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload; iron preparations for pharmaceutical and veterinary use in the nature of dietary supplements consisting primarily of iron; iron preparations as food supplements; glucose for medical purposes; diagnostic agents, preparations and substances for ...

Glucose for industrial purposes; glucose derivatives for industrial purposes; glucose oligo- and polysaccharides for industrial purposes; dextran being glucose for industrial purposes; dextran derivatives being glucose for industrial purposes; industrial chemicals, namely, excipients, cryoprotectants, lyoprotectants and media for use in storing, freezing, growing and thawing of human, plant or animal cells or tissue for non-medical purposes; industrial chemicals, namely, excipients, cryoprotectants, lyoprotectants and media in the nature of carbohydrates or carbohydrate derivatives, glucose, glucose derivatives, glucose oligo- and polysaccharides, dextran, and/or dextran derivatives, oligosaccharides, polysaccharides, derivatives of oligosaccharides and polysaccharides, glucose oligosaccharides, glucose polysaccharides, derivatives of glucose oligosaccharides and glucose polysaccharides, nanomolecules, iron nano molecules, polynuclear iron carbohydrate complexes, iron oligosaccharides ...

Scientific research for medical, veterinary and chemical purposes; scientific research in the nature of conducting clinical trials in the field of treatment and/or prevention of iron deficiency and/or anaemia or of iron overload; scientific research for medical and chemical purposes in the field of storing, freezing, growing and/or thawing biological material, cells, cancer cells and stem cells; providing medical and scientific research information relating to pharmaceuticals and clinical trials; molecular weight testing services for scientific research purposes
pharmacosmos

General Information


Serial Number79363592
Word MarkPHARMACOSMOS
Filing DateMonday, November 28, 2022
Status700 - REGISTERED
Status DateTuesday, July 2, 2024
Registration Number7431033
Registration DateTuesday, July 2, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 16, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload in humans; veterinary preparations for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload in animals; dietary supplements for human beings and animals; dietetic food and substances, namely, beverages adapted for medical and veterinary purposes; diagnostic preparations for medical and veterinary purposes; molecular weight testing reagents for diagnostic purposes; medical, pharmaceutical and veterinary preparations for parenteral administration, in particular oral, intravenous, intramuscular and subcutaneous, for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload; iron preparations for pharmaceutical and veterinary use in the nature of dietary supplements consisting primarily of iron; iron preparations as food supplements; glucose for medical purposes; diagnostic agents, preparations and substances for medical purposes, namely, excipients, cryoprotectants, lyoprotectants and media for use in storing, growing, freezing and thawing of human, plant or animal cells or tissue for medical or veterinary purposes, not for manufacturing; diagnostic agents, preparations and substances for medical purposes, namely, excipients, cryoprotectants, lyoprotectants and media in the nature of carbohydrates in solid, liquid or gaseous state for use in storing, freezing, growing and thawing of human, plant or animal cells or tissue for medical or veterinary purposes not for manufacturing; diagnostic agents, preparations and substances for medical purposes, namely, excipients, cryoprotectants, lyoprotectants and media in the nature of non-carbohydrates in solid, liquid or gaseous state for use in storing, freezing, growing and/or thawing of human, plant or animal cells or tissue for medical or veterinary purposes not for manufacturing; biological tissue cultures for medical and veterinary purposes; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload; chemical preparations for veterinary purposes, namely, for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload; chemical reagents for medical or veterinary purposes
Pseudo MarkPHARMA COSMOS
Goods and ServicesGlucose for industrial purposes; glucose derivatives for industrial purposes; glucose oligo- and polysaccharides for industrial purposes; dextran being glucose for industrial purposes; dextran derivatives being glucose for industrial purposes; industrial chemicals, namely, excipients, cryoprotectants, lyoprotectants and media for use in storing, freezing, growing and thawing of human, plant or animal cells or tissue for non-medical purposes; industrial chemicals, namely, excipients, cryoprotectants, lyoprotectants and media in the nature of carbohydrates or carbohydrate derivatives, glucose, glucose derivatives, glucose oligo- and polysaccharides, dextran, and/or dextran derivatives, oligosaccharides, polysaccharides, derivatives of oligosaccharides and polysaccharides, glucose oligosaccharides, glucose polysaccharides, derivatives of glucose oligosaccharides and glucose polysaccharides, nanomolecules, iron nano molecules, polynuclear iron carbohydrate complexes, iron oligosaccharides complexes, iron polysaccharide complexes, iron chelators, written transfection agents, in solid, liquid or gaseous state for use in storing, freezing, growing and thawing of human, plant or animal cells or tissue for non-medical purposes; industrial chemicals, namely, excipients, cryoprotectants, lyoprotectants and media in the nature of non-carbohydrates in solid, liquid or gaseous state for use in storing, freezing, growing and thawing of human, plant or animal cells or tissue for non-medical purposes; chemicals for use as excipients, cryoprotectants, lyoprotectants and media in the manufacture of pharmaceuticals; biological tissue cultures other than for medical or veterinary purposes; chemicals for use in the manufacture of cosmetics; chemicals for use in the manufacture of food supplements; industrial chemicals, namely, carbohydrates or carbohydrate derivatives, glucose, glucose derivatives, glucose oligo- and/or polysaccharides, dextran, and dextran derivatives for use in chromatography, separation systems, molecular weight measurements, lyophilization, cell media, transfection, and industrial applications; nanopowders for industrial purposes; industrial chemicals, namely, excipients, cryoprotectants, lyoprotectants and media for use in storing, growing, freezing and thawing of human, plant or animal cells or tissue for research purposes
Goods and ServicesScientific research for medical, veterinary and chemical purposes; scientific research in the nature of conducting clinical trials in the field of treatment and/or prevention of iron deficiency and/or anaemia or of iron overload; scientific research for medical and chemical purposes in the field of storing, freezing, growing and/or thawing biological material, cells, cancer cells and stem cells; providing medical and scientific research information relating to pharmaceuticals and clinical trials; molecular weight testing services for scientific research purposes

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, March 13, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 13, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePharmacosmos Holding A/S
Party Type30 - Original Registrant
Legal Entity Type65 - NOT AVAILABLE
AddressDK

Party NamePharmacosmos Holding A/S
Party Type20 - Owner at Publication
Legal Entity Type65 - NOT AVAILABLE
AddressDK

Party NamePharmacosmos Holding A/S
Party Type10 - Original Applicant
Legal Entity Type65 - NOT AVAILABLE
AddressDK

Trademark Events


Event DateEvent Description
Thursday, February 23, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, March 3, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, March 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 17, 2023APPLICATION FILING RECEIPT MAILED
Tuesday, July 18, 2023ASSIGNED TO EXAMINER
Tuesday, July 25, 2023NON-FINAL ACTION WRITTEN
Wednesday, July 26, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, August 19, 2023REFUSAL PROCESSED BY MPU
Saturday, August 19, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, September 13, 2023REFUSAL PROCESSED BY IB
Sunday, December 17, 2023CORRECTION TRANSACTION RECEIVED FROM IB
Friday, January 5, 2024CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Tuesday, February 13, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 13, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 13, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 8, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 27, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 27, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 16, 2024NOTIFICATION PROCESSED BY IB
Tuesday, April 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, October 2, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB